Evidence map›Paper›PMID 33077658›Full record

ArticleAntimicrobial agents and chemotherapy2020

Single-Arm Open-Label Clinical Trial of Two Grams of Aztreonam for the Treatment of Neisseria gonorrhoeae.

Lindley A Barbee, Olusegun O Soge, Negusse Ocbamichael, Angela LeClair, Matthew R Golden

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lindley A BarbeeDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA lbarbee@uw.edu.ORCID 0000-0002-7189-5492
Olusegun O SogeDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-8504-2319
Negusse OcbamichaelPublic Health-Seattle & King County, HIV/STD Program, Seattle, Washington, USA.
Angela LeClairDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
Matthew R GoldenDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
Public Health – Seattle & King County · USUniversity of Washington · US

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Characterizing Extragenital Gonorrhea and Chlamydia: Natural History & HIV ImpactK23AI113185 · NIAID · UNIVERSITY OF WASHINGTON · PI BARBEE, LINDLEY · 2014 to 2018
$903k
NCATS NIH HHS UL1 TR002319NIAID NIH HHS K23 AI113185
6 · The paper itself

Abstract

The threat of ceftriaxone-resistant

Indexed as

GonorrheaUrethritisAnti-Bacterial AgentsAztreonamCeftriaxoneHumansMaleNeisseria gonorrhoeaeAnti-Bacterial AgentsAztreonamCeftriaxoneaztreonamN. gonorrhoeaetreatment

Identifiers

PMID33077658
PMCPMC7927842
OpenAlexW3092797271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.